Ask The Doctor with Lawrence I. Golbe, MD

March 31, 2021 @ 2:00 pm – 3:00 pm
Virtual Event

Join CurePSP for Ask The Doctor with Lawrence I. Golbe, MD.

Lawrence I. Golbe, MD is one of the world’s leading clinical experts in progressive supranuclear palsy (PSP) and related neurodegenerative conditions. Dr. Golbe will answers questions that were submitted during registration by patients and families about PSP, MSA, and CBD. Questions can be submitted to

Please note that any medications that are referred to in this video should not be tried unless under the supervision of a licensed professional.

This webinar will also be recorded and emailed out in the following days to all registrants. Previous webinars can be found here.

About Dr. Larry I. Golbe

Lawrence I. Golbe, MD is Emeritus Professor of Neurology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ. He graduated from Brown University and New York University School of Medicine and did residency training at NYU/Bellevue before joining Rutgers in 1983. He was Acting Chair of his department from 2000 to 2003 and was Program Director of its neurology residency from 2003 to 2018. His research is in the clinical genetics, clinimetrics and epidemiology of the parkinsonian disorders. In 1988 he co-led the first studies of the prevalence and risk factors in PSP. He led the clinical portion of the project that in 1997 identified the first known Mendelian mutation causing Parkinson’s disease in the gene for alpha-synuclein. He devised the PSP Rating Scale, which since its publication in 2007 has become the standard clinical measure and treatment outcome marker for PSP world-wide. His current research centers on a geographical cluster of PSP. He has worked closely with CurePSP since 1992, presently as Director of Clinical Affairs, chair of its Medical Advisory Board and a member of its Board of Directors. His hobbies include cooking, learning Italian, reading history and leading a nonprofit devoted to academics at his high school in Englewood, NJ.

Link to the webinar will be emailed out to registrants twice from Eventbrite before the event – the first one hour before the event and the second ten minutes before.